SOUL, MEDI-FUTURE’s brand-new Digital Mammography that was launched
last month, received favorable reviews in the European market
As soon as SOUL was introduced to the market in Europe, a deal for 10 units got closed last week,
and the export of the units will be completed during the month of June.
In addition, MEDI-FUTURE and MIS Healthcare, a U.K. partner, agreed with each other
to launch SOUL in U.K. in May. At the same time, MEDI-FUTURE planned to participate
in the U.K. Breast Cancer Symposium in June to start full-scale promotion.
Due to these circumstances, the superior quality of SOUL was once again proved.
These favorable reviews are expected to be a powerful spur to MEDI-FUTURE’s
expanding its European market share.
MEDI-FUTURE is a global healthcare IT company dedicated to women's breast care.
Create Women's Health and Beauty
1505, Startower, 37, Sagimakgol-ro 62 beon-gil, Jungwon-gu, Seongnam-si, Gyeonggi-do, South Korea 13211
TEL : +82-31-8018-5140
FAX : +82-31-8018-5141
E-mail : sales@medi-future.com